Skip to content
Search

Latest Stories

Follow Us:
Top Stories

Texas’ New Abortion Ban Aims To Stop Doctors From Sending Abortion Pills to the State

But doctors say they won’t stop providing care.

News

Illustration of the state of Texas' shape and a piece of mail.
(Emily Scherer for The 19th)

Texas’ massive new abortion law taking effect this week could escalate the national fight over mailing abortion pills.

House Bill 7 represents abortion opponents’ most ambitious effort to halt telehealth abortions, which have helped patients get around strict bans in Texas and other states after Roe v. Wade was overturned. The law, which goes into effect December 4, creates civil penalties for health care providers who make abortion medications available in Texas, allowing any private citizen to sue medical providers for a minimum penalty of $100,000. The bill’s backers have said it would also allow suits against drug manufacturers. It would not enable suits against the people who get abortions.


Though other states have passed legislation targeting abortion medications — classifying them as a controlled substance, for instance — the Texas law is novel in its approach to targeting the people who distribute them and its reliance on civil suits.

Medical providers say the law won’t stop them from providing abortions to people in Texas. Three major telehealth practices confirmed that they intend to keep prescribing and mailing abortion medications to patients in Texas, citing other states’ laws that would shield them from Texas-based suits. Elisa Wells, the access director of Plan C, which lists abortion options for people across the country, said she has not heard from any providers about plans to stop offering telehealth abortions to Texans.

“If anything, the implementation of this law makes people more determined to help folks in Texas access abortion pills,” Wells said.

Pharmaceutical companies have not clarified how they will respond. Danco, one of the principal manufacturers of the abortion medication mifepristone, declined to comment. GenBioPro, which manufactures a generic version of the drug, also declined to comment.

However, anti-abortion activists who championed the law say they plan to launch civil lawsuits against health care providers who continue to mail medications to Texas. Those private suits could accelerate a clash between state abortion laws that is widely expected to be resolved by the conservative U.S. Supreme Court.

At issue is the conflict between individual state abortion restrictions and shield laws in other states that protect abortion providers from out-of-state prosecutions. Those laws say that state governments will not comply with extraterritorial efforts to punish health care providers for offering services legal in the state where they reside — including abortions. Almost half of all states have some form of shield law, though only eight explicitly protect providers no matter where a patient is located.

Under those laws, medical professionals living in states where abortion is legal have continued to mail medications patients can use to end their pregnancies from home — a method that is well-studied and effective with rare complications. Research suggests that 1 in 4 abortions are now done through telehealth, with about half of those in states with bans or restrictions.

The method’s popularity has made telehealth a top target for abortion opponents. No state has effectively halted the provision of telehealth abortions into states with bans, but HB 7’s implementation introduces a new tool for anti-abortion activists to leverage.

“We are building partnerships, we are educating our friends and other Texans about what the law is and what would be needed — and putting a team in place for if we actually need to bring one of these lawsuits at the end of the year,” said John Seago, head of the anti-abortion group Texas Right to Life, who played a leading role in shepherding HB 7.

That has involved meeting with abortion opponents across the state, including those who run anti-abortion centers, organizations that resemble medical clinics but instead deter people from terminating their pregnancies. Many also market services such as “post-abortion counseling.” Those offerings can put them in touch with people who have used telehealth for an abortion, and who could be sources for potential suits — especially given the dearth of dedicated reproductive health facilities in the state. Anti-abortion centers were a key source of support for HB 7.

“These contacts have the potential to come into contact with someone who had ordered these pills, or these pills were given to them, and they would have firsthand experience of how the pills got into Texas,” Seago said. “Those are the types of individuals we need to partner with to bring these lawsuits most effectively. We are definitely building that network out.”

Already, health professionals mailing abortion pills to Texans have been sued. The state Attorney General Ken Paxton has brought a case against Margaret Carpenter, a physician in New York, for mailing abortion pills to the state. (In New York, state officials have cited the shield law in declining to enforce a Texas court’s ruling that fined Carpenter $113,000.) Jonathan Mitchell, a prominent lawyer who has helped craft many of the state’s anti-abortion laws, has brought wrongful death lawsuits — typically used to sue someone for a death caused by negligence or recklessness — against multiple telehealth providers, arguing an abortion is the death of a person. Those cases are still making their way through court.

The new law could strengthen Texas’ case against telehealth. Mitchell has indicated in court documents that he intends to amend at least one civil case — a wrongful death brought against California-based Dr. Remy Coeytaux — after the law takes effect. He did not respond to a request for an interview.

Health care providers are watching that case closely, with some saying it could provide key insight into whether and how the new law could affect their risk.

“That will give us some information about what this is going to look like and how that moves through the courts,” said Dr. Angel Foster, who founded the Massachusetts Medication Abortion Project, a major telehealth practice. “And again, it’s going to be an opportunity for us to see shield laws in action.”

HB 7 closely resembles a 2021 Texas law that effectively outlawed abortions after six weeks of pregnancies — the majority of abortions — months before the fall of Roe v. Wade. That law pioneered the use of private civil suits to stop the provision of most abortions.

Though the law halted abortion providers from operating in the state, there were no successful lawsuits against health care providers. That reality, coupled with the rise of blue state laws to protect health care providers, has left many who offer telehealth skeptical that the new Texas law will immediately reach them.

“We are confident this is exactly what the Massachusetts shield law is meant to protect us from: civil penalties related to providing legally protected reproductive health care, which is what we’re doing,” Foster said. “I’m not naive that there could easily be suits, and that means our lawyers will have to be involved in handling that. There’s energy involved in ignoring something. But we’re not changing anything about our practice and not anticipating any changes to our practice in regard to HB 7.”


Texas’ New Abortion Ban Aims To Stop Doctors From Sending Abortion Pills to the State was originally published by The 19th and is republished with permission.

Read More

A stethoscope, calculator, pills, and cash.

As ACA subsidies expire and Medicaid rolls shrink, millions could face higher premiums or lose coverage, reigniting a national healthcare debate.

Getty Images, athima tongloom

How Expiring Subsidies and Medicaid Cuts Could Reshape U.S. Access to Care

Current Issue

In the coming year, millions of Americans could see their health insurance premiums rise, or lose coverage entirely, as key federal supports for affordable care are set to expire. The American Rescue Plan Act of 2021 (ARPA) subsidies under the Affordable Care Act (ACA) marketplace, which were later extended by the Inflation Reduction Act, are scheduled to expire at the end of 2025. According to one analysis, if these enhanced subsidies expire, premiums on average could increase by 25-100 percent. At the same time, several states are reducing Medicaid rolls following the end of the pandemic-era continuous coverage requirement. Over 25 million people had been disenrolled from Medicaid and CHIP during this process in 2024. Together, these changes could redefine U.S. healthcare access, reigniting debates about public health and fiscal restraint.

Background

The ACA, passed in 2010, aimed to make health insurance more accessible for millions of uninsured Americans by expanding Medicaid eligibility and creating subsidized plans under the premium tax credit. The ARPA of 2021 significantly increased those marketplace subsidies, eliminating the 400% of poverty threshold for eligibility and reducing the percentage of income that enrollees must pay in premiums. As a result, the number of people eligible for marketplace subsidies increased from 18.1 million to 21.8 million from 2020-2021. Meanwhile, pandemic policies prevented states from disenrolling almost all Medicaid and CHIP enrollees for over three years. When this continuous coverage requirement ended in April of 2023, states began to reevaluate the eligibility of tens of millions of people. The expiration of ARPA temporary subsidies combined with the end of continuous Medicaid coverage set the stage for a contentious healthcare market next year.

Keep ReadingShow less
U.S. Healthcare in 2025: Chaos, Costs, and Controversy Without Real Progress
a person wearing a blue shirt with a white circle on it
Photo by Nappy on Unsplash

U.S. Healthcare in 2025: Chaos, Costs, and Controversy Without Real Progress

The year 2025 has been one of the most turbulent years in modern U.S. healthcare. The headlines were explosive, the rhetoric dramatic, and the controversies nonstop. Yet for all the hoopla and upheaval, the medical care Americans receive now, month in and month out, looks no better than what they experienced on January 1 — but far more expensive.

Here are five areas of healthcare that generated chaos, confusion, and conflict in 2025 without meaningful improvement.

Keep ReadingShow less
University Roundtable Puts Latino Mental Health Front and Center

woman holds "Hablo Espanol" button

Picture Provided

University Roundtable Puts Latino Mental Health Front and Center

“Keep it to yourself. Push it down. Don’t say anything.” That is how Isis Lara Fernandez was taught to live with her status as an undocumented immigrant in the United States.

At 6-years-old, Lara Fernandez fled to the U.S. with her mother and siblings to escape domestic violence in Honduras. From that point forward, Lara Fernandez navigated life with a persistent fear that her secret could be discovered at any point in time.

Keep ReadingShow less
The Health Care Debate & Feldstein’s Fix
black and gray stethoscope

The Health Care Debate & Feldstein’s Fix

Serving in Congress during the implementation of President Barack Obama’s Affordable Care Act, Republicans embraced the position of “repeal and replace.” Repeal the ACA, but replace it with what? The debate is front-and-center again, though the ground has shifted some. There is more support for the ACA. Even some Republicans are looking to temporarily extend COVID-era subsidies for ACA health plans. Other Republicans want Health Savings Accounts, so more money goes to individuals instead of insurance companies. Democratic leadership seeks an approach temporarily extending the expanded premium subsidies, during which the entire approach to health care can be rethought.

The late economist Martin Feldstein had the fix: Martin Feldstein proposed a voucher system in which everyone could purchase a health insurance plan covering health care expenses exceeding 15% of their income. This could be combined with HSAs if they prove popular with the public.

Keep ReadingShow less